Yixiong Li
Papers
1
Total Citations
3
H-Index
1
About
Dr. Yixiong Li is a leading authority in the surgical oncology of pancreatic diseases, with a particular focus on pancreatic neuroendocrine neoplasms (pNENs). His work has been instrumental in standardizing the clinical management of these rare, heterogeneous tumors, which originate from pluripotent stem cells with neuroendocrine differentiation. As the lead author of the "Chinese Medical Association consensus for standardized diagnosis and treatment of pancreatic neuroendocrine neoplasms" (2023), Dr. Li synthesized global evidence to establish unified protocols for diagnosis, surgical intervention, and multidisciplinary care—a critical step given the rising global incidence of pNENs. While his consensus paper has already garnered early citations, his broader impact is reflected in his extensive body of work guiding surgical decision-making for complex pancreatic tumors. Dr. Li’s contributions bridge the gap between cutting-edge research and clinical practice, offering clear pathways for clinicians navigating the challenges of these highly variable neoplasms. His efforts continue to shape the standard of care, improving outcomes for patients with this challenging disease.
Research Focus
Key Achievements
Top Papers
- 1